Table 6.
Frequency distribution of identified resistance profiles—N (%).
| Antimicrobial | [µg] * | Susceptible | Intermediate | Resistant | Total |
|---|---|---|---|---|---|
| Cefoxitin | 30 | 228 (97.4) | 3 (1.3) | 3 (1.3) | 234 (100) |
| Ceftazidime | 30 | 198 (84.6) | 28 (12.0) | 8 (3.4) | 234 (100) |
| Ceftriaxone | 30 | 214 (91.5) | 16 (6.8) | 4 (1.7) | 234 (100) |
| Cefepime | 30 | 179 (76.5) | 50 (21.4) | 5 (2.1) | 234 (100) |
| Imipenem | 10 | 102 (43.6) | 98 (41.9) | 34 (14.5) | 234 (100) |
| Piperacillin-tazobactam | 110 | 207 (88.5) | 18 (7.7) | 9 (3.8) | 234 (100) |
| Chloramphenicol | 30 | 208 (88.9) | 22 (9.4) | 4 (1.7) | 234 (100) |
| Florfenicol | 30 | 107 (45.7) | 49 (20.9) | 78 (33.4) | 234 (100) |
| Tetracycline | 30 | 172 (73.5) | 36 (15.4) | 26 (11.1) | 234 (100) |
| Ciprofloxacin | 5 | 110 (47.0) | 89 (38.0) | 35 (15.0) | 234 (100) |
| Enrofloxacin | 5 | 34 (14.5) | 119 (50.9) | 81 (34.6) | 234 (100) |
| Sulfonamide | 300 | 8 (3.4) | 9 (3.9) | 217 (92.7) | 234 (100) |
| Trimethoprim-sulfamethoxazole | 25 | 98 (41.9) | 18 (7.7) | 118 (50.4) | 234 (100) |
| Erythromycin | 15 | 5 (2.1) | 175 (74.8) | 54 (23.1) | 234 (100) |
| Gentamicin | 10 | 203 (86.8) | 21 (9.0) | 10 (4.2) | 234 (100) |
| Amikacin | 30 | 186 (79.5) | 33 (14.1) | 15 (6.4) | 234 (100) |
* [µg.]—Antimicrobials disc concentration.